Literature DB >> 23680957

AngioJet rheolytic thrombectomy in patients presenting with high-risk pulmonary embolism and cardiogenic shock: a feasibility pilot study.

Robert F Bonvini1, Marco Roffi, Henri Bounameaux, Stéphane Noble, Hajo Müller, Pierre-Frédéric Keller, Philippe Jolliet, François P Sarasin, Olivier T Rutschmann, Karim Bendjelid, Marc Righini.   

Abstract

AIMS: Pulmonary embolism (PE) associated with haemodynamic instability has exceedingly high mortality. While intravenous thrombolysis is considered the therapy of choice, percutaneous mechanical thrombectomy may represent an alternative treatment. METHODS AND
RESULTS: The impact of AngioJet® rheolytic thrombectomy (RT) in PE associated with cardiogenic shock was assessed in a single-centre prospective pilot study. Ten consecutive PE patients in cardiogenic shock were included in the study. Six patients had thrombolysis contraindications, eight were intubated before the RT procedure and six had experienced cardiac arrest prior to the RT procedure. The RT procedure was technically successful in all cases. The Miller index improved from 25 to 20 (p=0.002). The shock index decreased from 1.22 to 0.9 (p=0.129). Thrombolytic agents were administered during or after the procedure in four patients because of progressive clinical deterioration. Seven patients died in the first 24 hours: two from multi-organ failure, one from post-anoxic cerebral oedema, and four from progressive right heart failure. The three survivors had favourable outcomes at one year.
CONCLUSIONS: This study suggests that the AngioJet® RT procedure may be safely performed in PE patients with cardiogenic shock. However, despite angiographic and haemodynamic improvements, the procedure does not appear to influence the dismal prognosis of these high-risk patients.

Entities:  

Mesh:

Year:  2013        PMID: 23680957     DOI: 10.4244/EIJV8I12A215

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

1.  A seven-year single-center experience on AngioJet rheolytic thrombectomy in patients with pulmonary embolism at high risk and intermediate-high risk.

Authors:  Özgur Yaşar Akbal; Berhan Keskin; Hacer Ceren Tokgöz; Aykun Hakgör; Ali Karagöz; Seda Tanyeri; Barkın Kültürsay; Şeyhmus Külahçıoğlu; Zübeyde Bayram; Süleyman Efe; Atakan Erkılınç; İbrahim Halil Tanboğa; Cem Doğan; Mehmet Akbulut; Nihal Özdemir; Cihangir Kaymaz
Journal:  Anatol J Cardiol       Date:  2021-12       Impact factor: 1.596

Review 2.  Management of Acute Pulmonary Embolism.

Authors:  Connor Tice; Matthew Seigerman; Paul Fiorilli; Steven C Pugliese; Sameer Khandhar; Jay Giri; Taisei Kobayashi
Journal:  Curr Cardiovasc Risk Rep       Date:  2020-10-06

3.  Endovascular thrombectomy with the AngioJet System for the treatment of intermediate-risk acute pulmonary embolism: a case report of two patients.

Authors:  Paweł Latacz; Marian Simka; Tomasz Ludyga; Tadeusz J Popiela; Tomasz Mrowiecki
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-02-11       Impact factor: 1.426

Review 4.  Pulmonary Embolism and Pregnancy-Challenges in Diagnostic and Therapeutic Decisions in High-Risk Patients.

Authors:  Lukas Hobohm; Ioannis T Farmakis; Thomas Münzel; Stavros Konstantinides; Karsten Keller
Journal:  Front Cardiovasc Med       Date:  2022-03-08

5.  Angiojet System Used in the Treatment of Submassive Pulmonary Embolism: A Case Report of Two Patients.

Authors:  Jinbo Liu; Tianrun Li; Wei Huang; Na Zhao; Hongwei Zhao; Hongyu Wang
Journal:  Case Rep Vasc Med       Date:  2022-08-23

6.  Outcomes of catheter-directed interventions in high-risk pulmonary embolism-a retrospective analysis.

Authors:  Freyr Einarsson; Charlotte Sandström; Kristina Svennerholm; Jonatan Oras; Christian Rylander
Journal:  Acta Anaesthesiol Scand       Date:  2020-11-27       Impact factor: 2.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.